Brief: Catalyst Biosciences Engages Perella Weinberg Partners To Assist The Company In Exploring Strategic Alternatives
17/02/2022 13:21
Feb 17 (Reuters) - Catalyst Biosciences Inc CBIO.O :
* CATALYST BIOSCIENCES ENGAGES PERELLA WEINBERG PARTNERS TO
ASSIST
THE COMPANY IN EXPLORING STRATEGIC ALTERNATIVES
Source text for Eikon: ID:nGNX7MMKXd
Further company coverage: CBIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gyre Therapeutics
See all newsBrief: Gyre Therapeutics - Enters Employment Agreement With Ying Luo As CEO - SEC Filing
Gyre Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Gyre Therapeutics, Inc. expected to post a loss of 13 cents a share - Earnings Preview
Brief: Gyre Therapeutics Reports Second Quarter 2026
Gyre Therapeutics Q2 revenue beats estimates on higher ETUARY sales volumes